3,29-O-Dibenzoyloxykarounidiol
CAS No. 389122-01-4
3,29-O-Dibenzoyloxykarounidiol( —— )
Catalog No. M24348 CAS No. 389122-01-4
3,29-O-Dibenzoyloxykarounidiol is a natural product with regulate blood sugar level, has potent inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) induced by tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 117 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3,29-O-Dibenzoyloxykarounidiol
-
NoteResearch use only, not for human use.
-
Brief Description3,29-O-Dibenzoyloxykarounidiol is a natural product with regulate blood sugar level, has potent inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) induced by tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA).
-
Description3,29-O-Dibenzoyloxykarounidiol is a natural product with regulate blood sugar level, has potent inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) induced by tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorEBV-EA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number389122-01-4
-
Formula Weight648.9
-
Molecular FormulaC44H56O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 2 mg/mL (3.08 mM)
-
SMILESCC1(C)[C@H](OC(C2=CC=CC=C2)=O)CC[C@]3(C)C4=CC[C@@]5(C)[C@]6([H])C[C@](C)(COC(C7=CC=CC=C7)=O)CC[C@@](C)6CC[C@@](C)5C4=CC[C@@]13[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
12(S)-HETE
12(S)-HETE is the predominant lipoxygenase product of mammalian platelets. It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1μM181M.
-
Silyamandin
Silyamandin may have antihepatotoxic and chemopreventive activities.
-
Milatuzumab
Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death.
Cart
sales@molnova.com